Get notified regarding key financial metrics and revenue changes at PerspectaLearn more
Banner background

Perspecta Revenue

Perspecta revenue was $4.5 b in FY, 2020 which is a 11.8% year over year increase from the previous period.

Embed Graph

Summary - Funding Rounds

Founding Date

2018

Total Funding

$692 m

Investors

In total, Perspecta had raised $692 m. Perspecta is a subsidiary of Peraton

Perspecta Revenue Breakdown

Embed Graph

Perspecta revenue breakdown by business segment: 68.8% from Defense and Intelligence and 31.2% from Civilian and Health Care

Perspecta Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020

Revenue

2.8b4.0b4.5b

Revenue growth, %

43%12%

Cost of goods sold

2.2b3.0b3.5b

Gross profit

664.0m987.0m1.0b

Gross profit Margin, %

24%24%23%

General and administrative expense

182.0m300.0m303.0m

Operating expense total

453.0m754.0m1.6b

Depreciation and amortization

167.0m330.0m374.0m

Interest expense

12.0m121.0m137.0m

Pre tax profit

199.0m112.0m(730.0m)

Income tax expense

(9.0m)40.0m(54.0m)

Net Income

208.0m72.0m(676.0m)

EPS

1.50.4(4.2)

Perspecta Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020

Cash

88.0m147.0m

Accounts Receivable

354.0m484.0m513.0m

Prepaid Expenses

74.0m141.0m81.0m

Current Assets

449.0m878.0m887.0m

PP&E

290.0m368.0m307.0m

Goodwill

2.0b3.2b2.7b

Total Assets

3.7b6.1b5.4b

Accounts Payable

195.0m246.0m218.0m

Short-term debt

160.0m217.0m239.0m

Current Liabilities

605.0m1.0b1.1b

Long-term debt

144.0m2.5b2.4b

Total Debt

304.0m2.7b2.7b

Total Liabilities

950.0m3.9b4.0b

Common Stock

2.0m2.0m

Additional Paid-in Capital

2.2b2.3b

Retained Earnings

2.0m(713.0m)

Total Equity

2.7b2.2b1.4b

Debt to Equity Ratio

0.1 x1.2 x2 x

Debt to Assets Ratio

0.1 x0.4 x0.5 x

Financial Leverage

1.3 x2.8 x4 x

Perspecta Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020

Net Income

208.0m72.0m(676.0m)

Depreciation and Amortization

167.0m330.0m374.0m

Accounts Receivable

49.0m102.0m97.0m

Accounts Payable

113.0m(18.0m)14.0m

Cash From Operating Activities

530.0m462.0m626.0m

Purchases of PP&E

(18.0m)(26.0m)(17.0m)

Cash From Investing Activities

(34.0m)(1.3b)(210.0m)

Short-term Borrowings

(50.0m)(150.0m)

Long-term Borrowings

(157.0m)(342.0m)(234.0m)

Dividends Paid

(1.0b)(38.0m)

Cash From Financing Activities

(496.0m)955.0m(294.0m)

Net Change in Cash

99.0m122.0m

Interest Paid

19.0m115.0m127.0m

Income Taxes Paid

11.0m61.0m32.0m

Perspecta Ratios

USDFY, 2018

Revenue/Employee

366.1k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.3 x

Perspecta Operating Metrics

FY, 2018Q1, 2019Q2, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020FY, 2020Q1, 2021Q2, 2021Q3, 2021

Backlog

$8.99 b$10.17 b$10.68 b$10.42 b$12.7 b$13.25 b$13.35 b$13.52 b$13.89 b$13.57 b

Backlog (Defense and Intelligence)

$1.98 b$2 b$6.64 b$1.99 b$1.97 b$8.06 b$8.34 b$8.46 b$8.59 b$8.49 b

Backlog (Civilian and Health Care)

$7.01 b$8.17 b$4.04 b$8.53 b$10.74 b$5.16 b$5.01 b$5.07 b$5.31 b$5.07 b

Contract Awards

$1.32 b$2.36 b$6.8 b$1 b$2.31 b$1.61 b$6.09 b$1.18 b$1.77 b$864 m

Contract Awards (Defense and Intelligence)

$345 m$1.7 b$4.7 b$669 m$1.93 b$515 m$3.78 b$863 m$1.02 b$744 m

Contracts Awards (Civilian and Health Care)

$975 m$664 m$2.1 b$332 m$372 m$1.1 b$2.31 b$313 m$751 m$120 m

Remaining Performance Obligations

$3.6 b$3.84 b

Patents Issued

270

New Patents

17

Facility Space, sq. ft.

1.8 m2.7 m2.7 m

New Government-Funded Research Projects Launched

18

Medicare Insurance Claims Processed

665 m

Office 365 Mailbox Migrations

90 k

Interfaces Created

19

Unauthorized Intrusion Attempts Prevented per Year

2.5 b2.5 b

Threats Detected

300 m300 m

Perspecta Employee Rating

3.5788 votes
Culture & Values
3.3
Work/Life Balance
3.5
Senior Management
3.2
Salary & Benefits
3.2
Career Opportunities
3.2
Source